Brachytherapy: Why Chemotherapy May Soon Be a Thing of the Past
Brachytherapy is considered to be one of the oldest techniques for the treatment of various cancers, particularly for prostate cancer.
feature2
May 2 – 3 2012, NYBA 21st Annual Meeting
New York Biotechnology Association (NYBA) will develop its Emerging Companies Showcase through a partnership with OneMedPlace.
“Brooklyn Doc Billionaire” Will Unveil Potential Cure For AIDS
The film will focus on current biotechnology “innovation-stagnation” , the current cost of drug development and its stages, and conflicts of interest based on human defense concepts.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Risk Trends Among Financiers in Healthcare
Richard Day Research, a leading clinical research organization, is conducting an evaluation on risk trends among financiers in the healthcare field. The insights of leading investors are a critical part of assessing shifts in the healthcare landscape.
PLC Announces Ministry of Health Approval to Distribute RenalGuard® in Israel
Under the terms of the agreement, A.M.I. will be the exclusive distributor of PLC’s RenalGuard in Israel, expanding RenalGuard’s distribution to the Middle East.
New Pharma Magazine Provokes Original Thinking & Stimulates Discussion on Future of Healthcare
New Pharma Magazine aims to provoke original thinking, ideas and debate on the future of the generic, over-the-counter, biosimilar, and animal health sectors.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
MPR Associates Discuss Brainstorming in Medical Device Development and wearing “Six Hats”
Cameron Loper and Brian Scrivens of MPR Associates discuss brainstorming and how it can bring a medical device to market.
Polymedix’s antibiotics are designed to imitate the mechanism of natural human immunity
PolyMedix has a pipeline of innovative infectious disease and cardiovascular product candidates.